Filing Details
- Accession Number:
- 0001593968-20-002189
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-12 16:24:50
- Reporting Period:
- 2020-11-10
- Accepted Time:
- 2020-11-12 16:24:50
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1771917 | Karuna Therapeutics Inc. | KRTX | Pharmaceutical Preparations (2834) | 270605902 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1777760 | Craig Andrew Miller | C/O Karuna Therapeutics, Inc. 33 Arch St Ste 3110 Boston MA 02110-1424 | Chief Operating Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-11-10 | 4,286 | $7.27 | 37,286 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-11-10 | 4,286 | $103.80 | 33,000 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2020-11-10 | 9,047 | $9.20 | 42,047 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-11-10 | 9,047 | $103.80 | 33,000 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2020-11-11 | 8,333 | $9.20 | 41,333 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-11-11 | 8,333 | $100.01 | 33,000 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2020-11-12 | 8,334 | $9.20 | 41,334 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-11-12 | 8,334 | $100.00 | 33,000 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Option (right to buy) | Disposition | 2020-11-10 | 4,286 | $0.00 | 4,286 | $7.27 |
Common Stock | Option (right to buy) | Disposition | 2020-11-10 | 9,047 | $0.00 | 9,047 | $9.20 |
Common Stock | Option (right to buy) | Disposition | 2020-11-11 | 8,333 | $0.00 | 8,333 | $9.20 |
Common Stock | Option (right to buy) | Disposition | 2020-11-12 | 8,334 | $0.00 | 8,334 | $9.20 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
19,971 | 2018-09-15 | 2028-08-09 | No | 4 | M | Direct |
340,016 | 2019-04-21 | 2029-03-21 | No | 4 | M | Direct |
331,683 | 2019-04-21 | 2029-03-21 | No | 4 | M | Direct |
323,349 | 2019-04-21 | 2029-03-21 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.